- Ongoing, recruitingTherapeutic exploratory (Phase II)
TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action
This study is testing a new capsule treatment for different types of depression. Researchers want to see if it helps improve mood and understand how it works in the body. It's an early-stage study open to adults aged 18 and over.
For: Unipolar/bipolar depressive disorderGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
This study is testing a new medicine, AMX0035, for people with Motor Neurone Disease (ALS). It aims to see if the medicine can slow down the disease's progression over 48 weeks, compared to a dummy medicine.
For: Amyotrophic Lateral Sclerosis (ALS)Netherlands · Poland · Germany